Patent Application for Biodegradable Particles Delivering Therapeutic Agents
Summary
The USPTO has published a new patent application (US20260083830A1) for biodegradable polymeric particles designed for the extended, controlled release of positively charged therapeutic agents at neutral pH. The application details microparticles and nanoparticles comprising an uncapped polymer matrix and a net positively charged therapeutic agent.
What changed
This document is a publication of a patent application filed with the USPTO, specifically application US20260083830A1. It describes biodegradable microparticles and nanoparticles made from polymers like PLGA or PLA, designed to deliver positively charged therapeutic agents, such as proteins or peptides, with extended and controlled release at neutral pH. The application also covers methods for making and administering these particles.
As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it represents potential future intellectual property in the field of drug delivery systems. Companies involved in pharmaceutical development, particularly those working with protein or peptide therapeutics and advanced delivery mechanisms, should be aware of this filing for competitive intelligence and potential licensing opportunities.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
BIODEGRADABLE POLYMERIC PARTICLES FOR DELIVERY OF POSITIVELY CHARGED THERAPEUTIC AGENTS
Application US20260083830A1 Kind: A1 Mar 26, 2026
Inventors
Steven Paul Schwendeman, James Moon, Corrine Din
Abstract
The disclosure relates to microparticles and nanoparticles comprising a polymer matrix comprising an uncapped polymer and a net positively charged therapeutic agent at neutral pH. More particularly the disclosure relates to PLGA and/or PLA particles comprising an uncapped polymer for extended, controlled release of positively charged proteins or peptides at neutral pH. Methods of making the particles and administering the particles are also provided.
CPC Classifications
A61K 39/0008 A61K 9/1647 A61K 9/1694 A61P 37/06 A61K 2039/6093 A61K 2039/627
Filing Date
2023-09-06
Application No.
19109261
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.